Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2022-09-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Colonography Versus Colonoscopy in High Risk Patient
NCT00748449
Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer
NCT02877056
Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer
NCT03107650
Textbook Outcome in Colon Carcinoma
NCT05675904
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
NCT04678011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Use of risk prediction scores
The prediction model is being used to identify patients who are at highest risk for colorectal cancer based on their risk scores.
Logistic regression risk model
Logistic regression model to assign risk score, plus time overdue and PROMPT risk category
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Logistic regression risk model
Logistic regression model to assign risk score, plus time overdue and PROMPT risk category
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hereditary colorectal cancer syndrome (e.g. Lynch syndrome)
* Diagnostic, fecal immunochemical test -positive, or screening indication for colonoscopy
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Permanente Medical Group
UNKNOWN
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodore R Levin, MD
Role: PRINCIPAL_INVESTIGATOR
Kaiser Permanente Northern California, Division of Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Northern California Division of Research
Oakland, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1547728-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.